Chinese
Develop high quality cell line in shorter time
Accelerate biologics development from target to market
One-stop solutions for biologics discovery and development featuring high quality and flexibility
Over 1,000 customers from 30+ countries and regions, including academia, pharma and biotech.
Our team and leaders have years of experience in global biopharma companies. Our PMs are trained scientists with PhD degree in the US and Europe.
We support flexible collaboration models that fit different projects to meet diversified customer needs. In projects with limited budget, upon request, we take on more roles throughout the project life cycle.
GenScript ProBio developed the distinguishing Phase-appropriate Compliance (PAC) quality system to meet worldwide stringent regulatory standards (including US-FDA/EU-EMA/China-NMPA), which will benefit our customers in a way of high quality, cost-effectiveness, efficiency and credibility.
Current capacity: up to 20 GCT IND and 400 L biologics. Total 16,800 L bioreactors by 2023.
GenScript Biotech's Biologics R&D and Production Center is Formally Put Into Operation.
GenScript-Thermo Fisher Strategic Partnership on Life Sciences and Biopharma.
China's Largest Plasmid and Virus Facility from GenScript was Put into Operation.
GenScript Biotech Global Forum at JP Morgan Healthcare Conference, San Francisco, CA, USA
